(Q37072381)

18 August 2017

1 reference

title

Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis (English)

1 reference

18 August 2017

0 references

1 reference

Sally Ayoub

1

1 reference

18 August 2017

Michael J Hickey

series ordinal

2

1 reference

18 August 2017

Eric F Morand

series ordinal

3

1 reference

18 August 2017

publication date

1 February 2008

1 reference

18 August 2017

number of pages

8

1 reference

Nature Clinical Practice Rheumatology

inferred from page(s)

published in

1 reference

18 August 2017

volume

4

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

98-105

1 reference

Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

Essential role of MAPK phosphatase-1 in the negative control of innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

Long-term prognosis and causes of death in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Prognostic value of endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

MIF signal transduction initiated by binding to CD74

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

New therapeutic target in inflammatory disease: macrophage migration inhibitory factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Expression of macrophage migration inhibitory factor in human glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Enhancement of oxidised low-density lipoprotein uptake by macrophages in response to macrophage migration inhibitory factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Stabilization of Atherosclerotic Plaques by Blockade of Macrophage Migration Inhibitory Factor After Vascular Injury in Apolipoprotein E–Deficient Mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

MAPK phosphatases--regulating the immune response

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Macrophage migration inhibitory factor and glucocorticoid sensitivity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0701

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0701

1 reference

Dimensions Publication ID

18 August 2017

1034151274

0 references

1 reference